plaque psoriasis
Phase 2b Trial: TAK-279 Improves Skin Clearance for Moderate to Severe Plaque Psoriasis
Results from a phase 2b trial indicate that the investigational drug TAK-279 (Takeda) significantly improved ...
MARCH 20, 2023
Cimzia Receives New Indication for Moderate to Severe Plaque Psoriasis
The FDA approved a new indication for Cimzia to treat moderate to severe plaque psoriasis in adults.
MAY 30, 2018
Load more